Feedback / Questions
ENS-002 - Concerto Biosci
https://www.prnewswire.com/news-releases/concerto-biosciences-announces-positive-topline-results-from-phase-1b-clinical-trial-of-ens-002-in-patients-with-atopic-dermatitis-302596913.html
Oct 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next